MIAN
EW icon

Mariner Independent Advisor Network’s Edwards Lifesciences EW Stock Holding History

Mariner Independent Advisor Network’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-40,638
Closed -$1.27M – 222
2017
Q1 		$1.27M Buy
+40,638
New +$1.27M 0.16% 88

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mariner Independent Advisor Network's EW Position: Q2 2017 in Review

Mariner Independent Advisor Network sold out of Edwards Lifesciences (EW) in Q2 2017, closing a stake of 40,638 shares — an estimated $1.27M sold.

Mariner Independent Advisor Network first reported a position in EW in Q1 2017 and held it in 1 quarter. The position peaked at $1.27M in Q1 2017. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.

  • Mariner Independent Advisor Network reported no remaining Edwards Lifesciences position as of Q2 2017 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 40,638 Edwards Lifesciences shares in Q2 2017, an estimated $1.27M.
  • Mariner Independent Advisor Network first reported a position in Edwards Lifesciences in Q1 2017 and held it in 1 quarter.
  • Mariner Independent Advisor Network's Edwards Lifesciences position peaked at $1.27M in Q1 2017.
  • 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2017, filed 16 Aug 2017.